We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GMP Deviations at Sanofi Plant Lead to Untitled Letter
GMP Deviations at Sanofi Plant Lead to Untitled Letter
September 7, 2010
Sanofi Pasteur SA has received an FDA untitled letter after failure to report biological product deviations, control microbial contamination and establish control systems to prevent contamination or product mix-ups.